| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0020-7519(01)00171-0 |
| P8608 | Fatcat ID | release_yoymnxsbsrhapbk7ilcqmzbmsi |
| P698 | PubMed publication ID | 11334946 |
| P2093 | author name string | Minoprio P | |
| P2860 | cites work | Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents | Q33826635 |
| A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase | Q33912838 | ||
| Chagas' disease is attenuated in mice lacking gamma delta T cells | Q35462991 | ||
| "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue | Q36107611 | ||
| Mimicry in Trypanosoma cruzi: fantasy and reality | Q36845308 | ||
| Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells | Q38241650 | ||
| Mutual cell interactions and the selection of immune repertoires: implication in autoimmunity | Q39579892 | ||
| A CD4+ TH2 cell line isolated from mice chronically infected with Trypanosoma cruzi induces IgG2 polyclonal response in vivo | Q41736368 | ||
| Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses | Q42139425 | ||
| Significant association between the skewed natural antibody repertoire of Xid mice and resistance to Trypanosoma cruzi infection. | Q54021474 | ||
| Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease. | Q54296976 | ||
| A Trypanosoma cruzi Alkaline Antigen Induces Polyclonal B-Cell Activation of Normal Murine Spleen Cells by T-Cell-Independent, BCR-Directed Stimulation | Q57842251 | ||
| A 24 000 MW Trypanosoma cruzi antigen is a B-cell activator | Q57842275 | ||
| Skewed Vβ TCR repertoire of CD8+ T cells in murine Trypanosoma cruzi infection | Q57842353 | ||
| Preferential expansion of Ly-1 B and CD4− CD8− T cells in the polyclonal lymphocyte responses to murine T.cruzi infection | Q57842408 | ||
| Most B Cells in Acute Trypanosoma cruzi Infection Lack Parasite Specificity | Q57842433 | ||
| Polyclonal Lymphocyte Responses to Murine Trypanosoma cruzi Infection | Q57842451 | ||
| Polyclonal Lymphocyte Responses to Murine Trypanosoma cruzi Infection | Q57842458 | ||
| Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses | Q58846249 | ||
| P433 | issue | 5-6 | |
| P304 | page(s) | 588-591 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | International Journal for Parasitology | Q6051284 |
| P1476 | title | Parasite polyclonal activators: new targets for vaccination approaches? | |
| P478 | volume | 31 |
| Q34090268 | 2,3-diphenyl-1,4-naphthoquinone: a potential chemotherapeutic agent against Trypanosoma cruzi |
| Q35133901 | A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection |
| Q51982627 | A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. |
| Q33981753 | Acute chagas disease: new global challenges for an old neglected disease |
| Q55426170 | Anti-band 3 and anti-spectrin antibodies are increased in Plasmodium vivax infection and are associated with anemia. |
| Q58844788 | Apoptosis differentially regulates mesenteric and subcutaneous lymph node immune responses to Trypanosoma cruzi |
| Q35725257 | B-Cell Response during Protozoan Parasite Infections |
| Q33573335 | BAFF mediates splenic B cell response and antibody production in experimental Chagas disease. |
| Q29615136 | Chagas disease |
| Q37264799 | Chagas heart disease pathogenesis: one mechanism or many? |
| Q54648155 | Characterization of the B-cell immune response elicited in BALB/c mice challenged with Neospora caninum tachyzoites. |
| Q39146653 | Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial |
| Q41552272 | Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease |
| Q40394529 | Differential infectivity and immunopathology in murine experimental infections by two natural clones belonging to the Trypanosoma cruzi I lineage |
| Q33479115 | Differential regional immune response in Chagas disease |
| Q26772721 | Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection |
| Q51778104 | Haematological and histopathological findings after ovariectomy in Trypanosoma cruzi infected mice. |
| Q37145013 | Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy |
| Q33518569 | IgG autoantibody to brain beta tubulin III associated with cytokine cluster-II discriminate cerebral malaria in central India |
| Q36385476 | Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry |
| Q43169575 | Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection |
| Q35994773 | Innate and acquired immunity in the pathogenesis of Chagas disease |
| Q26749609 | Interactions between Trypanosoma cruzi Secreted Proteins and Host Cell Signaling Pathways |
| Q34500622 | Pathogenesis of Chagas heart disease: role of autoimmunity |
| Q30936576 | Phylogenetic and syntenic data support a single horizontal transference to a Trypanosoma ancestor of a prokaryotic proline racemase implicated in parasite evasion from host defences |
| Q58853398 | Sequence diversity and differential expression of Tc52 immuno-regulatory protein in Trypanosoma cruzi: potential implications in the biological variability of strains |
| Q34221892 | Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria |
| Q33631293 | Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice |
| Q43640153 | T-bet-dependent regulation of CD8+ T-cell expansion during experimental Trypanosoma cruzi infection |
| Q34385087 | The MASP family of Trypanosoma cruzi: changes in gene expression and antigenic profile during the acute phase of experimental infection |
| Q34032964 | Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease. |
Search more.